Abstract

ObjectiveRepetitive transcranial magnetic stimulation (rTMS) can effectively improve depression symptoms in patients with major depressive disorder (MDD); however, its mechanism of action remains obscure. This study explored the neuralimaging mechanisms of rTMS in improving depression symptoms in patients with MDD.MethodsIn this study, MDD patients with first-episode, drug-naive (n = 29) and healthy controls (n = 33) were enrolled. Depression symptoms before and after rTMS treatment were assessed using the Hamilton Depression Rating Scale (HAMD-17). Resting-state functional magnetic resonance imaging (rs-fMRI) data were collected both before and after the treatment. Changes in the brain function after the treatment were compared using the following two indices: the amplitude of the low-frequency fluctuation (ALFF) and regional homogeneity (ReHo), which are sensitive for evaluating spontaneous neuronal activity. The brain region with synchronous changes was selected as the seed point, and the differences in the causal connectivity between the seed point and whole brain before and after rTMS treatment were investigated via Granger causality analysis (GCA).ResultsBefore treatment, patients with MDD had significantly lower ALFF in the left superior frontal gyrus (p < 0.01), higher ALFF in the left middle frontal gyrus and left precuneus (p < 0.01), and lower ReHo in the left middle frontal and left middle occipital gyri (p < 0.01) than the values observed in healthy controls. After the rTMS treatment, the ALFF was significantly increased in the left superior frontal gyrus (p < 0.01) and decreased in the left middle frontal gyrus and left precuneus (p < 0.01). Furthermore, ReHo was significantly increased in the left middle frontal and left middle occipital gyri (p < 0.01) in patients with MDD. Before treatment, GCA using the left middle frontal gyrus (the brain region with synchronous changes) as the seed point revealed a weak bidirectional causal connectivity between the middle and superior frontal gyri as well as a weak causal connectivity from the inferior temporal to the middle frontal gyri. After treatment, these causal connectivities were strengthened. Moreover, the causal connectivity from the inferior temporal gyrus to the middle frontal gyri negatively correlated with the total HAMD-17 score (r = −0.443, p = 0.021).ConclusionrTMS treatment not only improves the local neural activity in the middle frontal gyrus, superior frontal gyrus, and precuneus but also strengthens the bidirectional causal connectivity between the middle and superior frontal gyri and the causal connectivity from the inferior temporal to the middle frontal gyri. Changes in these neuroimaging indices may represent the neural mechanisms underlying rTMS treatment in MDD.Clinical Trial RegistrationThis study was registered in the Chinese Clinical Trial Registry (Registration number: ChiCTR1800019761).

Highlights

  • Major depressive disorder (MDD) is a mental illness characterized by mood disorders and cognitive dysfunction

  • Patients with MDD had lower amplitude of the low-frequency fluctuation (ALFF) in the left superior frontal, right inferior temporal, left middle occipital, and right inferior occipital gyri as well as higher ALFF in the left precuneus and left middle frontal gyrus than the values observed in healthy controls (Table 3 and Figure 1)

  • After 15 days of repetitive transcranial magnetic stimulation (rTMS) treatment, the ALFF was increased in the left superior frontal gyrus and decreased in the left precuneus and left middle frontal gyrus of patients with MDD (Table 4 and Figure 1)

Read more

Summary

Introduction

Major depressive disorder (MDD) is a mental illness characterized by mood disorders and cognitive dysfunction. Blood-oxygen-level-dependent magnetic resonance imaging works based on the principle of detecting changes in the magnetic field properties due to the changes in local metabolism and blood oxygen level after neuronal activity (Tian et al, 2020). This imaging method has been widely used in exploring the pathophysiology of and therapeutic mechanism for MDD (Tateishi et al, 2020). The amplitude of the low-frequency fluctuation (ALFF) in the blood-oxygen-level-dependent signal is used to describe the amplitude of the spontaneous activity of the brain neurons, and larger ALFF indicates greater activity in the brain region. The ALFF and ReHo can evaluate the spontaneous activity of neurons from different perspectives, and these two indices are complementary to each other (Kong et al, 2017)

Methods
Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.